The Controlled Substances Act, 2023.

Controlled Substances [No. 2 of 2023 5
THE CONTROLLED SUBSTANCES ACT, 2023
ARRANGEMENT OF SECTIONS
PART I
PRELIMINARY PROVISIONS
Section
1. Short title and commencement
2. Interpretation
PART II
ADMINISTRATION
3. Administration of Act
4. Functions of Authority
PART III
LICENSING FOR CONTROLLED SUBSTANCES
5. Non-application of Part III
6. Prohibition of manufacturing, importing, exporting, dealing in or advertising
of controlled substance
7. Application for licence
8. Renewal of licence
9. Suspension or revocation of licence
10. Amendment of licence
11. Submission of quarterly returns
12. Transfer of licence
13. Notice of cessation of activity by licensee
PART IV
MANUFACTURING, SUPPLY, DISTRIBUTION, SELLING, USING, PRESCRIBING AND
DISPENSING OF CONTROLLED SUBSTANCES
14. National annual requirements for controlled substances
15. Prohibition of placing on market, e.t.c., controlled substance used as
medicine without pharmaceutical licence
16. Application for pharmaceutical licence
17. Authorisation for certain classes of persons
18. Prescribing or dispensing controlled substances
19. Withdrawal and restoration of authorisation
20. Sell or supply without prescription
21.

ersons
18. Prescribing or dispensing controlled substances
19. Withdrawal and restoration of authorisation
20. Sell or supply without prescription
21.

Sell or supply by partial filling of prescription
22. Emergency sell or supply of controlled substance
23. Retail of precursor chemicals
24. Consignment of controlled substance in transit
25. Prohibition of diversion of controlled substance within Republic
26. Use of controlled substances in health research
Single copies of this Act may be obtained from the Government Printer,
P.O. Box 30136, 10101 Lusaka, Price K 92.00 each.

substances in health research
Single copies of this Act may be obtained from the Government Printer,
P.O. Box 30136, 10101 Lusaka, Price K 92.00 each.

6 No. 2 of 2023] Controlled Substances
PART V
CLASSIFICATION AND EXEMPTION OF CONTROLLED SUBSTANCES
27. Classification of controlled substances
28. Exemptions for certain purposes
29. Non-prescription preparation containing controlled substance
30. Temporary classification of controlled substances to avoid
imminent hazards to public safety
31. Temporary and permanent classification of anabolic steroids
PART VI
REPORTS, RECORDS, INVENTORIES AND REGISTERS
32. Records or inventory of licensed activity
33. Registers by other person or institution
34. Preservation of documents
PART VII
INSPECTIONS
35. Power of authorised officer
36. Powers of arrest
PART VIII
OFFENCES AND PENALTIES
37. Maintaining controlled substances involved premises
38. Sale of controlled substance to children
39. Employing, hiring, using, persuading, inducing, enticing or
coercing children to distribute drugs
40. Prohibition of possession of controlled substance
41. Offence of import, export, manufacture, possession and use
of prepared opium
42. General penalty
43. Offence by principal officer, shareholder or partner of body
corporate or unincorporate body
PART IX
GENERAL PROVISIONS
44. Waiver by Authority
45.

3. Offence by principal officer, shareholder or partner of body
corporate or unincorporate body
PART IX
GENERAL PROVISIONS
44. Waiver by Authority
45.

Appeals
46. Disposal of controlled substance
47. Requirements in respect of cessation of practise
48. Forfeiture
49. Guidelines
50. Power of Minister to amend Schedules
51. Regulations
52. Repeal of Act No. 42 of 1967 and savings and transitional
provisions
SCHEDULES

Guidelines
50. Power of Minister to amend Schedules
51. Regulations
52. Repeal of Act No. 42 of 1967 and savings and transitional
provisions
SCHEDULES

Enactment
Controlled Substances [No. 2 of 2023 7
An Act to provide for the granting of a licence to deal in,
manufacture, import and export a controlled substance;
regulate the use, dispensing, manufacture, wholesale,
transfer, supply, sell, distribution and possession of a
controlled substance for medicinal, scientific and research
purposes; provide for procedures and criteria for
classification of controlled substances; provide for the
functions of the Zambia Medicines and Regulatory
Authority relating to controlled substances; repeal and
replace the Dangerous Drugs Act, 1967; and provide for
matters connected with, or incidental to, the foregoing. [18th April, 2023
ENACTED by the Parliament of Zambia. 1. This Act may be cited as the Controlled Substances Act,
2023, and shall come into operation on the date that the Minister
may appoint, by statutory instrument. 2.

be cited as the Controlled Substances Act,
2023, and shall come into operation on the date that the Minister
may appoint, by statutory instrument. 2.

In this Act, unless the context otherwise requires—
“administer” has the meaning assigned to the word in the
Medicines and Allied Substances Act, 2013;
“adulterant” means a substance found within a controlled
substance that compromises the quality, safety or
effectiveness of that controlled substance;
“agent” means a person who acts on behalf, or on the
direction, of a licensed entity when carrying out the licensed
entity’s business;
Short title
and
commence-
ment
Act No. 3 of
2013
Interpretation
GOVERNMENT OF ZAMBIA
ACT
No. 2 of 2023
Date of Assent: 14th April, 2003

ty’s business;
Short title
and
commence-
ment
Act No. 3 of
2013
Interpretation
GOVERNMENT OF ZAMBIA
ACT
No. 2 of 2023
Date of Assent: 14th April, 2003

8 No.

8 No.

2 of 2023] Controlled Substances
“anabolic steroid” includes a hormonal substance, chemical
or pharmacological substance related to testosterone;
“animal health facility” has the meaning assigned to the words
in the Veterinary and Veterinary Para-Professions Act,
2010;
“appropriate authority” means a relevant public body, statutory
corporation or person having powers or regulatory functions
under any other written law;
“authorised dispenser” means a pharmacist, veterinary
surgeon or any other person authorised by the Authority to
dispense a controlled substance;
“authorised officer” means a person assigned to carry out
the duties of a law enforcement authority for the purposes
of this Act and includes—
(a) an officer appointed under the Narcotic Drugs and
Psychotropic Substances Act, 2021;
(b) an inspector appointed under the Medicines and Allied
Substances Act, 2013; and
(c) an inspector appointed under the Environmental
Management Act, 2011;
“authorised prescriber” has the meaning assigned to the words
in the Medicines and Allied Substances Act, 2013;
“authorised seller” means a registered pharmacist in a
pharmacy or veterinary surgeon in an agro veterinary shop
of a specified class, who is authorised to sell controlled
substances as prescribed and any other person authorised
by the Authority;
“Authority” means the Zambia Medicines Regulatory
Authority established under the Medicines and Allied
Substances Act, 2013;
“child” has the meaning assigned to the word in the
Constitution;
“coca leaves” means the leaves of any plant of the genus of
the erythroxylaceae from which cocaine can be extracted,
either directly or by chemical transformation;
“Commission on Narcotic Drugs” means the United Nations
Commission on Narcotic Drugs established by the
Economic and Social Council in 1946, to assist the
Economic and Social Council in supervising the application
of the international drug control treaties;
Act No.

d Social Council in 1946, to assist the
Economic and Social Council in supervising the application
of the international drug control treaties;
Act No.

45
of 2010
Act No. 35
of 2021
Act No. 3 of
2013
Act No. 12 of
2011
Act No. 3 of
2013
Act No. 3 of
2013
Cap. 1

45
of 2010
Act No. 35
of 2021
Act No. 3 of
2013
Act No. 12 of
2011
Act No. 3 of
2013
Act No. 3 of
2013
Cap. 1

Controlled Substances [No.

Controlled Substances [No.

3 of 2023 9
“controlled substance” means a narcotic drug, psychotropic
substance or precursor chemical set out in the First, Second,
Third, Fourth, Fifth and Sixth Schedules, but does not include
distilled spirits, wine, malt beverages or tobacco as defined
in the Customs and Excise Act;
“Convention on Psychotropic Substances” means the
Convention on Psychotropic Substances which entered into
force on 16th August 1976, and was acceded to by the
Republic on 28th May, 1993;
“deal” has the meaning assigned to the word in the Medicines
and Allied Substances Act, 2013 and includes research for
medicinal and scientific purposes and
“dealt” shall be construed accordingly;
“denaturant” means a substance which renders a controlled
substance unfit for consumption without destroying the
usefulness in other applications;
“dispense” means to count, measure or decant a controlled
substance from a bulk supply or to prepare, mix, dissolve
or supply a controlled substance but does not include the
administration of medicine;
“distribute” means the division and movement of controlled
substances from the premises of a manufacturer, or from
another central point to an intermediate point, or to an end
user, by means of any method of transport;
“distributor” means a person who distributes a controlled
substance;
“diversion” means a change of the intended use or destination
of a controlled substance;
“drug addict” means a person addicted to a narcotic drug or
psychotropic substance;
“Drug Enforcement Commission” means the Drug
Enforcement Commission established under the
Constitution;
“health facility” has the meaning assigned to words in the
Health Professions Act, 2009;
“health practitioner” means a medical doctor, medical
licentiate, pharmacist, dental surgeon or other person as
the Minister may, on the advice of the Authority, by statutory
instrument, designate;
“health research” has the meaning assigned to the words in
the National Health Research Act, 2013;
Cap.

Authority, by statutory
instrument, designate;
“health research” has the meaning assigned to the words in
the National Health Research Act, 2013;
Cap.

322
Act No. 3 of
2013
Cap. 1
Act No. 24 of
2009
Act No. 2 of
2013

322
Act No. 3 of
2013
Cap. 1
Act No. 24 of
2009
Act No. 2 of
2013

10 No.

10 No.

2 of 2023] Controlled Substances
“higher education institution” has the meaning assigned to the
word in the Higher Education Act, 2013;
“international agreements” means the United Nations Single
Convention on Narcotic Drugs, 1961, or any other
agreement relating to, or impacting on, controlled
substances to which the Republic is a party to;
“legally disqualified” means the absence of legal capacity as
provided in section 4 of the Mental Health Act, 2019;
“licence” means a licence issued under section 6;
“licensee” means a person licensed in accordance with this
Act;
“manufacture” in relation to a controlled substance, includes
any process carried out in the course of making that
controlled substance but does not include dissolving or
dispensing a product in, or diluting or mixing it with, some
other substance for purposes of administering it;
“medicine” has the meaning assigned to the word in the
Medicines and Allied Substances Act, 2013;
“medical doctor” means a person registered as a medical doctor
under the Health Professions Act, 2009;
“medicinal purposes” means the use of a controlled substance
for the treatment or prevention of a disease or for some
other definite curative or therapeutic purpose, but excludes
the satisfaction or relief of a habit or craving for the
controlled substance;
“narcotic drug” means a narcotic drug set out in the First, Second,
Third and Fourth Schedules;
“National Health Research Authority” means the National
Health Research Authority established under the National
Health Research Act, 2013;
“pharmacist” means a person registered as a pharmacist under
the Health Professions Act, 2009;
“possess” includes to keep or store a controlled substance, or to
have a controlled substance in custody or under control or
supervision;
“precursor chemical” has the meaning assigned to the words in
the Narcotic Drugs and Psychotropic Substances Act,
2021;
Act No.

ontrol or
supervision;
“precursor chemical” has the meaning assigned to the words in
the Narcotic Drugs and Psychotropic Substances Act,
2021;
Act No.

4 of
2013
Act No. 6 of
2019
Act No. 3 of
2013
Act No. 24 of
2009
Act No. 2 of
2013
Act No. 24 of
2009
Act No. 35 of
2021

4 of
2013
Act No. 6 of
2019
Act No. 3 of
2013
Act No. 24 of
2009
Act No. 2 of
2013
Act No. 24 of
2009
Act No. 35 of
2021

Controlled Substances [No.

Controlled Substances [No.

2 of 2023 11
“premises” includes any building, dwelling, shop, office or tent
together with the land on which the building, dwelling, shop,
office or tent is situated and the adjoining land used in
connection with that land, and includes any vehicle,
conveyance or vessel;
“preparation” means a solution or mixture in whatever physical
state containing a controlled substance;
“prescription” has the meaning assigned to the word in the
Medicines and Allied Substances Act, 2013;
“prepared opium” means opium prepared for smoking, and
includes dross and any other residues remaining after opium
has been smoked, and opium, for whatever purpose
prepared, which is capable of being smoked;
“psychoactive substance” means a narcotic drug or psychotropic
substance that has potential to affect how the brain
functions and causes changes in mood, awareness, thoughts,
feelings, or behaviour;
“psychotropic substance” has the meaning assigned to the words
in the Narcotic Drugs and Psychotropic Substances Act,
2021 and includes the psychotropic substances set out in
the First, Second, Third and Fourth Schedule;
“register” means a register of controlled substances provided
for under section 32;
“repealed Act” means the repealed Dangerous Drugs Act;
“sell” has the meaning assigned to the word in the Medicines
and Allied Substances Act, 2013;
“Single Convention” means the Single Convention on Narcotic
Drugs which entered into force on 8th August, 1975, and
was ratified by the Republic on 13th May, 1998;
“special stocks” means an amount of controlled substances held
by the Government for purposes determined by the
Government;
“stocks”means the amount of controlled substances held in the
Republic for medicinal, scientific and research purposes,
manufacture or export;
“temporary classification” means a temporary removal of a
controlled substance from or an addition to the First, Second,
Third or Fourth Schedule;
“veterinary surgeon” means a person registered as a veterinary
surgeon under the Veterinary and Veterinary Para-
Professions Act, 2010;
Act No.

edule;
“veterinary surgeon” means a person registered as a veterinary
surgeon under the Veterinary and Veterinary Para-
Professions Act, 2010;
Act No.

35
of 2021
Cap. 35
Act No. 3 of
2013
Act No. 45
of 2010
Act No. 3 of
2013

35
of 2021
Cap. 35
Act No. 3 of
2013
Act No. 45
of 2010
Act No. 3 of
2013

12 No. 2 of 2023] Controlled Substances
“Zambia Environmental Management Agency” means the
Zambia Environmental Management Agency established
under the Environmental Management Act, 2011; and
“Zambia Revenue Authority” means the Zambia Revenue
Authority established under the Zambia Revenue Authority
Act. PART II
ADMINISTRATION
3. (1) The Act shall be administered by the Authority. (2) The seal of the Authority kept in terms of the Medicines
and Allied Substances Act, 2013, shall be used for the purposes of
this Act and the impression made for that purpose shall be judicially
noticed. 4. (1) The Authority shall, in addition to the functions under
the Medicines and Allied Substances Act, 2013, perform the
functions conferred on the Authority under this Act.

ll, in addition to the functions under
the Medicines and Allied Substances Act, 2013, perform the
functions conferred on the Authority under this Act.

(2) The functions of the Authority are to —
(a) monitor, supervise and control special stocks and stocks,
in collaboration with the Drug Enforcement Commission
and other appropriate authorities, to ensure compliance
with this Act and any other written law;
(b) regulate and control the manufacture, importation,
exportation, distribution and sale of a controlled
substance;
(c) issue a licence to deal in, import, export, store, manufacture
and use, a controlled substance;
(d) collaborate with national, regional and international
organisations on matters relating to controlled
substances;
(e) co-ordinate the assessment on a psychoactive substance
with an appropriate authority and recommend to the
Minister possible control measures under international
agreements; and
(f)advise the Minister on a matter relating to a controlled
substance. PART III
LICENSING FOR CONTROLLED SUBSTANCES
5. (1) This part shall not apply to a controlled substance that
is listed under the Sixth Schedule. Act No. 12
of 2011
Act No. 3 of
2013
Administration
of Act
Functions of
Authority
Act No. 3 of
2013
Non-
application
of Part III

r the Sixth Schedule. Act No. 12
of 2011
Act No. 3 of
2013
Administration
of Act
Functions of
Authority
Act No. 3 of
2013
Non-
application
of Part III

Controlled Substances [No. 2 of 2023 13
(2) A person who intends to manufacture, import,export, deal
in or advertise a controlled substance set out under the Sixth
Schedule shall apply for a licence to manufacture, import, export,
deal in or advertise the controlled substance in accordance with
the Environmental Management Act, 2011. (3) Despite subsection (2), a person who intends to import a
controlled substance set out in the Sixth Schedule shall, in addition
to the licence under subsection (2), apply to the Authority for
authorisation to import the controlled substance in the prescribed
manner and form. (4) The Authority shall, within thirty days of receipt of an
application under subsection (3), approve or reject the application. (5) The Authority shall, where the Authority
(a) approves an application under subsection (4), notify the
applicant, in writing; or
(b) rejects an application under subsection (4), notify the
applicant, in writing, stating the reasons for the rejection. 6. (1) A person shall not manufacture, import, export, deal in
or advertise a controlled substance without a licence issued by the
Authority.

jection. 6. (1) A person shall not manufacture, import, export, deal in
or advertise a controlled substance without a licence issued by the
Authority.

(2) A person who contravenes subsection (1) commits an
offence and is liable, on conviction, to imprisonment for a term not
exceeding twenty-five years but the term of imprisonment shall
not be less than two years. 7. (1) A person who intends to manufacture, import, export,
deal in or advertise a controlled substance set out in the Schedules
shall apply to the Authority for a licence in a prescribed manner
and form, on payment of a prescribed fee. (2) The Authority shall, within ninety days of receipt of an
application under subsection (1), approve or reject the application. (3) Despite subsection (2), the Authority shall approve or reject
an application to import or export a controlled substance within
fourteen days of the date of receipt of the application. (4) The Authority shall, where the Authority rejects an
application, inform the applicant of the Authority’s decision in a
prescribed manner and form stating the reasons for the rejection. (5) The Authority shall, where the applicant meets the
prescribed requirements issue the applicant with an applicable licence
in a prescribed manner and form. Act No.

y shall, where the applicant meets the
prescribed requirements issue the applicant with an applicable licence
in a prescribed manner and form. Act No.

12
of 2011
Prohibition
of
manufacturing,
importing,
exporting,
dealing in or
advertising
of
controlled
substance
Application
for licence

12
of 2011
Prohibition
of
manufacturing,
importing,
exporting,
dealing in or
advertising
of
controlled
substance
Application
for licence

14 No. 2 of 2023] Controlled Substances
(6) A licence granted under subsection (5) shall be valid for—
(a) one year, for an import and export licence;
(b) two years, for a manufacturing licence;
(c) the duration of the advert for a controlled substance for
an advertising licence; and
(d) a period as stated on the licence for other licences dealing
in controlled substances. 8. (1) A licensee who intends to renew a licence shall, within
ninety days before the expiration of the licence, apply to the
Authority for renewal of the licence in a prescribed manner and
form, on payment of a prescribed fee. (2) The Authority shall, within fourteen days of receipt of an
application under subsection (1), approve or reject the application. (3) The Authority shall, where the Authority rejects an
application, inform the applicant of the Authority’s decision in a
prescribed manner and form stating the reasons for the rejection. (4) The Authority shall, where the applicant meets the
prescribed requirements, renew the licence.

ner and form stating the reasons for the rejection. (4) The Authority shall, where the applicant meets the
prescribed requirements, renew the licence.

(5) The licensee shall, where a licensee does not intend to
renew the licence, within ninety days before the expiry of the licence,
submit to the Authority a status report relating to the licensed activity
in a prescribed manner and form. (6) Despite subsection (1), a licence to import or export a
controlled substance, is not renewable. 9. (1) The Authority shall suspend or revoke a licence where
the licensee—
(a) obtained the licence by fraud, misrepresentation or
concealment of a material fact;
(b) is legally disqualified to undertake the activity for which
the licence was issued;
(c) fails to take corrective measures following the suspension
of the licence;
(d) changes business premises without authorisation; or
(e) is convicted of an offence under the Act or any other
written law and sentenced to a term of imprisonment
exceeding six months without the option of a fine. (2) The Authority shall, before suspending or revoking a licence,
notify the licensee in a prescribed manner and form of the
Authority’s intention to suspend or revoke the licence and —
(a) give reasons for the intended suspension or revocation;
and
Renewal of
licence
Suspension
or revocation
of licence

end or revoke the licence and —
(a) give reasons for the intended suspension or revocation;
and
Renewal of
licence
Suspension
or revocation
of licence

Controlled Substances [No. 2 of 2023 15
(b) require the licensee to show cause, within a period as
the Authority may determine, why the licence should
not be suspended or revoked. (3) The Authority shall not suspend or revoke a licence under
this section if the licensee takes remedial measures to the
satisfaction of the Authority within the period specified under
subsection (2). (4) The Authority may suspend or revoke a licence if the
licensee, after being notified under subsection (2), fails to show
cause or does not take any remedial measures to the satisfaction
of the Authority. (5) The Authority shall, where a licence is revoked under
this Act, inform the licensee, in writing, of the revocation of the
licence and the licensee shall surrender that licence to the
Authority. 10. (1) A licensee who intends to amend a licence shall apply
to the Authority for an amendment of that licence in a prescribed
manner and form, on payment of a prescribed fee. (2) The Authority shall within fourteen days of receipt of an
application under subsection (1)—
(a) approve or reject the amendment; and
(b) notify the licensee of the approval of the amendment or
rejection thereof. 11.

tion under subsection (1)—
(a) approve or reject the amendment; and
(b) notify the licensee of the approval of the amendment or
rejection thereof. 11.

(1) A licensee shall submit to the Authority a quarterly
return on a controlled substance in a prescribed manner and form. (2) A quarterly return referred to under subsection (1) shall
be submitted not later than fourteen days of the next quarter. (3) A licensee who fails to submit a quarterly return within
the prescribed period commits an offence. 12. (1) A licence issued under this Part shall not be
transferred to a third party without prior authorisation of the
Authority. (2) A licensee who intends to transfer a licence shall apply
to the Authority in a prescribed manner and form, on payment of
a prescribed fee. (3) The Authority shall, within thirty days of receipt of an
application under subsection (2), approve or reject the application. (4) The Authority shall, where the Authority rejects the
application, inform the applicant in the prescribed manner and
form stating the reasons for the rejection. Amendment
of licence
Submission
of quarterly
returns
Transfer of
licence

cant in the prescribed manner and
form stating the reasons for the rejection. Amendment
of licence
Submission
of quarterly
returns
Transfer of
licence

16 No. 2 of 2023] Controlled Substances
(5) The Authority shall, where the person to whom a licensee
intends to transfer the licence meets the prescribed requirements,
transfer the licence to that person for the remainder of the validity
of the licence on terms and conditions that the Authority may
determine. (6) Despite subsection (2), an import or export licence is not
transferable. 13. (1) A licensee who intends to cease conducting a licensed
activity under this Act shall notify the Authority in a prescribed
manner and form. (2) A licensee shall, thirty days prior to the cessation of the
activity for which the licence was issued, submit to the Authority a
detailed report of the licensed activity in a prescribed manner and
form. (3) A licensee shall, where the licensed activity ceases before
the expiry of the licence, surrender the licence to the Authority and
the Authority shall, on terms and conditions that the Authority may
determine, cancel that licence. PART IV
MANUFACTURING, SUPPLY, DISTRIBUTION, SELLING, USING,
PRESCRIBING AND DISPENSING OF CONTROLLED SUBSTANCES
14.

y
determine, cancel that licence. PART IV
MANUFACTURING, SUPPLY, DISTRIBUTION, SELLING, USING,
PRESCRIBING AND DISPENSING OF CONTROLLED SUBSTANCES
14.

The Authority shall determine the total quantity, and
establish national annual requirements, for each class of a controlled
substance in order to provide for—
(a) requirements for medicinal, scientific and research
purposes;
(b) lawful export requirements;
(c) maintenance of reserve stocks;
(d) limitation or reduction of individual production quotas to
the extent necessary to prevent the aggregate of
individual quotas from exceeding the amount prescribed;
(e) revision of quotas for each class of a controlled substance,
where applicable; and
(f) determination of the process of fixing the production quota,
taking into account—
(i) the average estimated disposal, inventory and other
requirements of the manufacturing sector for
the year;
(ii) the trend of the national disposal rate during the
preceding year;
Notice of
cessation
of activity
by licensee
National
annual
requirements
for
controlled
substances

e national disposal rate during the
preceding year;
Notice of
cessation
of activity
by licensee
National
annual
requirements
for
controlled
substances

Controlled Substances [No. 2 of 2023 17
(iii) the average production cycle and inventory
position of the manufacturing sector;
(iv) the economic availability of raw materials, yield
and stability problems;
(v) national emergencies and disasters; or
(vi) any other factor that the Authority considers
necessary. 15. A person shall not place on the market, advertise, promote,
manufacture, sell, import, supply or deal with a controlled substance
used as a medicine without a pharmaceutical licence issued by the
Authority in accordance with the Medicines and Allied Substances
Act, 2013. 16. A person who intends to place on the market, advertise,
promote, manufacture, sell, import, supply or deal with a controlled
substance used as a medicine shall apply to the Authority for a
pharmaceutical licence in accordance with the Medicines and Allied
Substances Act, 2013, and shall meet the requirements prescribed
under this Act. 17.

harmaceutical licence in accordance with the Medicines and Allied
Substances Act, 2013, and shall meet the requirements prescribed
under this Act. 17.

(1) The following classes of persons are authorised for
the practice or exercise of that person’s profession, function or
employment, to be in possession of, dispose, use, prescribe or
dispense, a controlled substance:
(a) health practitioner;
(b) veterinary surgeon;
(c) nurse or midwife specified under section 51 of the Nurses
and Midwives Act, 2019;
(d) a person in charge of a laboratory used for the purpose of
research or education and attached to—
(i) a higher education institution;
(ii) a health facility; or
(iii) any research institution or registered business
entity; and
(e) an authorised officer. Prohibition
of placing on
market,
e.t.c.,
controlled
substance
used as
medicine
without
pharmaceutical
licence
Act No. 3 of
2013
Application
for
pharmaceutical
licence
Act No. 3 of
2013
Authorisation
for certain
classes of
persons
Act No. 10
of 2019

cal
licence
Act No. 3 of
2013
Application
for
pharmaceutical
licence
Act No. 3 of
2013
Authorisation
for certain
classes of
persons
Act No. 10
of 2019

18 No. 2 of 2023] Controlled Substances
(2) A person referred to under subsection (1) who is in
possession of a medicine containing a controlled substance, shall,
except when required by the practice of a profession, function or
employment, keep the medicine in a locked immovable receptacle
which shall be opened only by that person or another person
authorised by virtue of this section, to be in possession of a controlled
substance. 18. (1) An authorised prescriber may prescribe a controlled
substance for treatment in accordance with guidelines issued by
the Authority. (2) An authorised dispenser may dispense a controlled
substance for treatment in accordance with guidelines issued by
the Authority. (3) Guidelines issued under this section shall include matters
relating to—
(a) security of stocks of controlled substances;
(b) the maintenance of prescribed records on controlled
substances; and
(c) the quantities of controlled substances which may be
provided without supervision for use by an individual in
treatment. 19.

olled
substances; and
(c) the quantities of controlled substances which may be
provided without supervision for use by an individual in
treatment. 19.

(1) The Authority may, by notice in the Gazette, revoke
the authorisation of any person under section 16, where that
person—
(a) commits an offence under this Act, or attempts to solicit,
incite, aid or abet, any other person to commit any
offence under this Act;
(b) has that person’s licence or certificate of practice
suspended or revoked;
(c) is legally disqualified from, being in possession of, disposing,
using, prescribing or dispensing, a controlled substance;
or
(d) is proved, to the satisfaction of a medical doctor, to be a
drug addict. (2) A person whose authorisation is revoked in accordance
with subsection (1) may apply to the Authority in a prescribed
manner and form, on payment of a prescribed fee for the restoration
of that person’s authorisation. (3) The Authority may, where the authorisation of a person is
revoked in accordance with this section, restore the authorisation
where the reasons for revocation cease to exist. Prescribing
or
dispensing
controlled
substances
Withdrawal
and
restoration
of
authorisation

orisation
where the reasons for revocation cease to exist. Prescribing
or
dispensing
controlled
substances
Withdrawal
and
restoration
of
authorisation

Controlled Substances [No. 2 of 2023 19
(4) The Authority may, where the Authority revokes the
authorisation of a person, seize and take custody of the controlled
substance at the cost of the person whose authorisation has been
revoked. 20. A person shall not sell or supply a controlled substance
which requires a prescription without a prescription. 21. (1) Despite section 20 and any other written law governing
controlled substances, a person may sell or supply a controlled
substance for medicinal purposes on partial filling of a prescription
for a controlled substance set out in the First, Second, Third, Fourth
and Fifth Schedules if the—
(a) partial filling is requested by the patient or the authorised
prescriber that prescribed the controlled substance; and
(b) total quantity for the partial filling does not exceed the
total quantity prescribed. (2) Except as provided in this section, remaining portions of a
partially filled prescription for a controlled substance set out in the
First, Second, Third, Fourth and Fifth Schedules may be filled not
later than thirty days after the date on which the prescription was
written. 22.

he
First, Second, Third, Fourth and Fifth Schedules may be filled not
later than thirty days after the date on which the prescription was
written. 22.

(1) An authorised seller of a controlled substance who is
reasonably satisfied that a person requesting a controlled substance
is an authorised prescriber and by reason of some emergency is
unable to furnish a prescription immediately, may, in the absence of
a prescription, sell or supply the controlled substance requested in
accordance with the directions of the authorised prescriber, except
that the authorised prescriber shall undertake to furnish the
authorised seller with a prescription, within seven days of the
delivery of the controlled substance. (2) A person who fails to provide a prescription within the
period specified under subsection (1) commits an offence. 23. A retailer shall ensure that the sale of a product containing
precursor chemicals set out in the Fifth Schedule is made in
accordance with the guidelines issued by the Authority. 24.

sale of a product containing
precursor chemicals set out in the Fifth Schedule is made in
accordance with the guidelines issued by the Authority. 24.

(1) Where a controlled substance is permitted under the
law of any foreign country to be exported to another country, and
is transited through the Republic as provided in the Customs and
Excise Act, the exporter shall —
(a) notify the Authority, the Drug Enforcement Commission
and the Zambia Revenue Authority in the prescribed
manner and form; and
Sell or supply
without
prescription
Sell or
supply by
partial filling
of
prescription
Emergency
sell or
supply of
controlled
substance
Retail of
precursor
chemicals
Cap. 322
Consignment
of controlled
substance in
transit

of
prescription
Emergency
sell or
supply of
controlled
substance
Retail of
precursor
chemicals
Cap. 322
Consignment
of controlled
substance in
transit

20 No. 2 of 2023] Controlled Substances
(b) not cause, or procure, the controlled substance to be
diverted to any destination within the Republic without
authorisation. (2) A person who contravenes subsection (1) commits an
offence and is liable, on conviction, to a fine not exceeding five
hundred thousand penalty units or to imprisonment for a term not
exceeding five years, or to both. 25. (1) A person shall not without authorisation cause a
controlled substance to be diverted within the Republic to a
destination other than that which it was originally assigned. (2) A person who contravenes subsection (1) commits an
offence and is liable, on conviction, to a fine not exceeding five
hundred thousand penalty units or to imprisonment for a term not
exceeding five years, or to both. 26. (1) A person who intends to carry out health research on
a controlled substance set out in the First, Second, Third, Fourth,
Fifth and Sixth Schedules shall do so in accordance with the
National Health Research Act, 2013, and the Medicines and Allied
Substances Act, 2013.

h,
Fifth and Sixth Schedules shall do so in accordance with the
National Health Research Act, 2013, and the Medicines and Allied
Substances Act, 2013.

(2) The Authority and the National Health Research Authority
shall, in setting the criteria for assessing the merits of a research
protocol using a controlled substance, ensure that they are effective
procedures to adequately safeguard against diversion of a controlled
substance from legitimate medicinal, scientific or research purposes. (3) The Authority and the National Health Research Authority
shall, in setting the criteria for assessing the merits of a research
protocol using a controlled substance under subsection (2), take
into account—
(a) a person’s experience with respect to a controlled
substance;
(b) previous convictions relating to a controlled substance;
(c) relevant written laws relating to a controlled substance;
(d) medical and research experience of the person; and
(e) any other conduct which may threaten public health and
safety. Prohibition
of diversion
of controlled
substance
within
Republic
Act No. 2 of
2013
Act No. 3 of
2013
Use of
controlled
substances
in health
research

. Prohibition
of diversion
of controlled
substance
within
Republic
Act No. 2 of
2013
Act No. 3 of
2013
Use of
controlled
substances
in health
research

PART V
CLASSIFICATION AND EXEMPTION OF CONTROLLED SUBSTANCES
27. (1) The Minister may, by statutory instrument and on the
recommendation of the Authority, and in consultation with
appropriate authorities, classify a controlled substance in the First,
Second, Third, Fourth, Fifth or Sixth Schedule.

ority, and in consultation with
appropriate authorities, classify a controlled substance in the First,
Second, Third, Fourth, Fifth or Sixth Schedule.

(2) The Authority shall, in making the recommendation under
subsection (1), ensure that the classification is in accordance with
the following levels of potential abuse:
(a) in the case of a controlled substance classified in the First
Schedule, the controlled substance—
(i) has a high potential for abuse or poses a serious
threat to public health; or
(ii) is limited or has no use for research, medicinal or
scientific purposes;
(b) in the case of a controlled substance classified in the
Second Schedule, the controlled substance—
(i) has major stimulant and addictive properties;
(ii) has high potential for abuse or poses a serious
threat to public health;
(iii) has an approved medicinal or scientific purpose;
or
(iv) may lead to severe psychological or physical
dependence due to abuse;
(c) in the case of a controlled substance classified in the Third
Schedule, the controlled substance includes—
(i) preparations containing narcotic drugs that are
intended for legitimate medical use and are
compounded in such a way that the preparation
is unlikely to be abused and that the base
narcotic drug cannot be easily extracted; or
(ii) psychotropic substances which have legitimate
medical use, and poses a serious risk to public
health;
(d) in the case of a controlled substance classified in the Fourth
Schedule, the controlled substance —
(i) is rarely used in medical practice and may be
subject to special control measures; or
Classification
of controlled
substances
Controlled Substances [No.

rarely used in medical practice and may be
subject to special control measures; or
Classification
of controlled
substances
Controlled Substances [No.

2 of 2023 21

2 of 2023 21

22 No. 2 of 2023] Controlled Substances
(ii) includes psychotropic substances which have
legitimate use and poses a minor risk to public
health; and
(e) in the case of a controlled substance classified in the Fifth
and Sixth Schedule, the controlled substance is a
precursor chemical. 28. (1) Subject to section 31, the Authority shall, where the
Authority considers that a controlled substance does not have a
significant potential for abuse, recommend to the Minister to exempt
the controlled substance from the application of any provisions of
this Act. (2) The Minister may, on the recommendation of the Authority
and in consultation with an appropriate authority, exempt, by statutory
instrument, a controlled substance from the application of any
provisions of this Act.

onsultation with an appropriate authority, exempt, by statutory
instrument, a controlled substance from the application of any
provisions of this Act.

(3) The Minister may, on the recommendation of the Authority
and in consultation with an appropriate authority, by statutory
instrument, exempt any compound, mixture or preparation containing
a controlled substance from the application of any provisions of
this Act if the Authority finds that the compound, mixture or
preparation contains—
(a) a controlled substance which is not for administration to a
human being or animal, and which is packaged in a
form or concentration, or with adulterant or
denaturants, and it does not present any significant
potential for abuse; or
(b) an anabolic steroid, which is intended for administration
to a human being or an animal and which, because of its
concentration, preparation, formulation or delivery
system, does not present any significant potential for
abuse. (4) The Minister shall, by statutory instrument, revoke the
exemption of a controlled substance that the Authority finds is being
diverted from the purposes specified in subsection (2) or (3).

ument, revoke the
exemption of a controlled substance that the Authority finds is being
diverted from the purposes specified in subsection (2) or (3).

(5) The Minister shall, in revoking an exemption of a controlled
substance under this section, consider—
(a) the scope, duration and significance of the diversion;
(b) whether the controlled substance is formulated in a manner
that it cannot easily be used in the illicit production of
another controlled substance;
Exemptions
for certain
purposes

nce is formulated in a manner
that it cannot easily be used in the illicit production of
another controlled substance;
Exemptions
for certain
purposes

Controlled Substances [No. 2 of 2023 23
(c) whether a precursor can be readily recovered from the
controlled substance;
(d) the evidence of the diversion of the controlled substance;
and
(e) any other relevant issue that contravenes this Act and
any other written law. (6) Subject to subsection (8), the Minister shall, on the
recommendation of the Authority and in consultation with an
appropriate authority, on an application by a licensee of a controlled
substance, whose exemption is revoked by statutory instrument,
reinstate the exemption of that controlled substance, where the
Minister is satisfied that the controlled substance shall be
manufactured, imported, exported and dealt with in a manner that
prevents diversion.

the
Minister is satisfied that the controlled substance shall be
manufactured, imported, exported and dealt with in a manner that
prevents diversion.

(7) The Minister shall, on the recommendation of the Authority,
in reinstating an exemption of a controlled substance, as specified
under subsection (6), consider—
(a) the package sizes and manner of packaging of the
controlled substance;
(b) the manner of distribution and advertising of the controlled
substance;
(c) any action taken by the manufacturer to prevent diversion
of the controlled substance; and
(d) other factors that are relevant to, and consistent with,
public health and safety, including the factors specified
in subsection (3). (8) A person shall not divert a controlled substance without
authorisation from the Authority as prescribed. (9) A person who contravenes subsection (8) commits an
offence and is liable, on conviction, to a penalty specified under the
Nacortic Drugs and Psychotropic Substances Act, 2021. 29. Subject to the Medicines and Allied Substances Act, 2013,
the Minister may, by statutory instrument, exempt a preparation
containing a controlled substance from the application of this Act,
if the preparation containing a controlled substance may be sold
over the counter without a prescription. Act No.

ce from the application of this Act,
if the preparation containing a controlled substance may be sold
over the counter without a prescription. Act No.

35 of
2021
Non-
prescription
preparation
containing
controlled
substance
Act No. 3 of
2013

35 of
2021
Non-
prescription
preparation
containing
controlled
substance
Act No. 3 of
2013

24 No. 2 of 2023] Controlled Substances
30. (1) Despite sections 28 and 29, the Minister may, on the
recommendation of the Authority, by statutory instrument, order
the temporary classification of a controlled substance to avoid an
imminent hazard to the public. (2) The Minister may, on the recommendation of the Authority,
by statutory instrument, remove a controlled substance from a
Schedule on a temporary basis, where reasons advanced for the
grant of the temporary classification cease to exist. 31. (1) The Minister may, on the recommendation of the
Authority, by statutory instrument, order the temporary classification
of an anabolic steroid as a controlled substance, if the Authority
finds that the classification shall assist in preventing abuse or misuse
of the anabolic steroid. (2) The Minister may, on the recommendation of the Authority,
by statutory instrument, remove an anabolic steroid from a Schedule
on a temporary basis, where the reasons advanced for the grant of
the temporary classification cease to exist.

ove an anabolic steroid from a Schedule
on a temporary basis, where the reasons advanced for the grant of
the temporary classification cease to exist.

(3) The Minister may, on the recommendation of the Authority,
by statutory instrument, permanently include an anabolic steroid as
a controlled substance in the appropriate Schedule. PART VI
REPORTS, RECORDS, INVENTORIES AND REGISTERS
32. (1) A licensee shall establish and maintain a complete and
accurate record or inventory of each controlled substance
manufactured, imported, exported, advertised or dealt in. (2) A health facility or animal health facility shall establish and
maintain a complete and accurate record or inventory of each
controlled substance in the health facility or animal health facility’s
possession, disposed of, used, prescribed or dispensed by a person
authorised under section 16. (3) In the case of a person in charge of a laboratory used for
the purpose of research or education and attached to a higher
education institution, research institution or registered business
entity, that higher education institution, research institution and
registered business entity shall establish and maintain a complete
and accurate record or inventory of each controlled substance.

arch institution and
registered business entity shall establish and maintain a complete
and accurate record or inventory of each controlled substance.

(4) The record or inventory referred to in this section shall be
kept and maintained in a prescribed manner and form. (5) A person who contravenes this section commits an offence. Temporary
classification
of controlled
substances to
avoid
imminent
hazards to
public safety
Temporary
and
permanent
classification
of anabolic
steroids
Records or
inventory of
licensed
activity

ances to
avoid
imminent
hazards to
public safety
Temporary
and
permanent
classification
of anabolic
steroids
Records or
inventory of
licensed
activity

Controlled Substances [No. 2 of 2023 25
33. (1) The Authority may require a person or institution, other
than a person or institution referred to under section 32, in possession
of a controlled substance for disposal, use, prescribing or dispensing
to keep and maintain a register of the controlled substances in that
person or institution’s possession in a prescribed manner and form. (2) A person who contravenes this section commits an offence. 34. (1) A licensee, a health facility, animal health facility, higher
education institution, research institution, registered business entity
or other person or institution so required by the Authority shall
preserve registers, records, inventories, books, prescriptions, orders
in writing and other documents issued or made for the purposes of
this Act for a period of five years from the date on which the last
entry was made or issued, as prescribed. (2) A person who contravenes this section commits an offence. PART VII
INSPECTIONS
35.

date on which the last
entry was made or issued, as prescribed. (2) A person who contravenes this section commits an offence. PART VII
INSPECTIONS
35.

(1) An authorised officer may, for the purpose of enforcing
the provisions of this Act, with a warrant, at any reasonable time—
(a) enter any premises, pharmacy, agro veterinary shop,
container, vessel, vehicle, aircraft or other conveyance
that the authorised officer has reasonable grounds to
believe is used for the commission of an offence or for
purposes contrary to the provisions of this Act;
(b) search any premises where any activity in relation to
controlled substances is being undertaken, including a
pharmacy, an agro veterinary shop, a container, vessel,
vehicle, an aircraft or other conveyance, or the premises
of a manufacturer, importer, exporter or dealer of any
controlled substances or any person licensed or regulated
under this Act, including a private dwelling, where
information or documents which may be relevant to an
inspection may be kept or which are being used for the
commission of an offence under this Act;
(c) search any person on the premises if the authorised officer
has reasonable grounds to believe that the person has
possession of an article, document, record or controlled
substance that has a bearing on an investigation, except
that a person shall only be searched by a person of the
same sex;
Registers by
other person
or institution
Preservation
of
documents
Power of
authorised
officer

son shall only be searched by a person of the
same sex;
Registers by
other person
or institution
Preservation
of
documents
Power of
authorised
officer

26 No.

26 No.

2 of 2023] Controlled Substances
(d) examine any document, record, book, article or controlled
substance found on the premises that has a bearing on
an inspection or investigation;
(e) require information to be given about any document,
record, book, article or controlled substance in any
premises by—
(i) the owner of the premises;
(ii) the person in control of the premises;
(iii) any person who has control of the document,
record, book, article or controlled substance; or
(iv) any other person who may have the information;
(f)seize any document, book, record, article, computer or other
electronic storage device or controlled substance that
has a bearing on an inspection or investigation or is used
for purposes contrary to the provisions of this Act;
(g) take samples of any controlled substance as may be
necessary for the purposes of testing, examination or
analysis;
(h) take extracts from, or make copies of, any book, record
or document found on the premises that has a bearing
on an inspection or investigation; or
(i) use any computer system or any other electronic device
on the premises, or require the assistance of any person
on the premises to use that computer system or
electronic device, to—
(i) search any data contained in, or available to, the
computer system or electronic device;
(ii) reproduce any record from the data;
(iii) seize any output from the computer or electronic
device for examination and copying; and
(iv) attach and, if necessary, remove from the
premises for examination and safeguarding any
document, record, book or article that has a
bearing on an inspection or investigation.

remove from the
premises for examination and safeguarding any
document, record, book or article that has a
bearing on an inspection or investigation.

(2) An authorised officer who removes any document, book,
record or article from any premises under subsection (1) shall—
(a) issue a receipt for the document, book, record or article
to the owner of, or person in control of, the premises;
and

under subsection (1) shall—
(a) issue a receipt for the document, book, record or article
to the owner of, or person in control of, the premises;
and

Controlled Substances [No. 2 of 2023 27
(b) return the document, book, record or article as soon as
practicable after achieving the purpose for which it
was removed. (3) A person commits an offence if that person—
(a) delays, assaults, threatens or obstructs an authorised officer
in the performance of the authorised officer’s functions;
(b) refuses to give an authorised officer reasonable assistance
that the authorised officer may require for the purpose
of exercising the authorised officer’s powers;
(c) gives an authorised officer false or misleading information
in answer to an inquiry made by the authorised officer;
or
(d) impersonates an authorised officer or presents oneself to
be an authorised officer. (4) A person convicted of an offence under subsection (3) is
liable, on conviction, to a fine not exceeding two hundred thousand
penalty units or to imprisonment for a term not exceeding two years,
or to both. (5) An authorised officer shall furnish a written report and
any other information relating to an inspection to an appropriate
authority, as the Authority may require.

officer shall furnish a written report and
any other information relating to an inspection to an appropriate
authority, as the Authority may require.

(6) Nothing in this section requires a person to disclose or
produce information or a document, if the person would in an action
in a court be entitled to refuse to disclose or produce the information
or document. 36. (1) An authorised officer may arrest a person, without
warrant, where the authorised officer has reasonable grounds to
believe that the person—
(a) is committing or has committed an offence under this
Act;
(b) is about to commit an offence under this Act and there is
no other way to prevent the commission of the offence;
(c) shall, unless arrested—
(i) escape or cause unreasonable delay, trouble or
expense in being made answerable to justice;
(ii) interfere with the witnesses; or
(iii) tamper with or destroy relevant evidence or
material; or
(d) is willfully obstructing the authorised officer in the execution
of the authorised officer’s duties. Powers of
arrest

ant evidence or
material; or
(d) is willfully obstructing the authorised officer in the execution
of the authorised officer’s duties. Powers of
arrest

28 No. 2 of 2023] Controlled Substances
(2) An authorised officer shall, where the authorised officer
arrests a person under subsection (1), handover the person to a
police officer, or surrender that person to a police post or station
within twenty four hours of the arrest. (3) An authorised officer who makes an arrest under
subsection (1) shall, without undue delay, have the person so arrested
brought before a court of competent jurisdiction to be dealt with
accordingly. PART VIII
OFFENCES AND PENALTIES
37. (1) Except as authorised by this Act, a person commits an
offence if that person—
(a) knowingly opens, leases, rents, uses or maintains any place,
whether permanently or temporarily, for the purpose of
manufacturing, distributing or using any controlled
substance; or
(b) manages or controls any place, whether permanently or
temporarily, either as an owner, lessee, agent, employee,
occupant or mortgagee, or knowingly and intentionally
rents, leases, profits from, or makes available for use,
with or without compensation, the place for the purpose
of unlawfully manufacturing, storing, distributing or using
a controlled substance.

e for use,
with or without compensation, the place for the purpose
of unlawfully manufacturing, storing, distributing or using
a controlled substance.

(2) A person convicted of an offence under subsection (1) is
liable, on conviction, to imprisonment for a term not exceeding five
years. 38. (1) Except as provided in this Act, a person who deals in
a controlled substance with a child commits an offence and is liable,
on conviction, to a fine not exceeding two million penalty units or to
imprisonment for a term not exceeding fifteen years, or to both. (2) Where the controlled substance referred to under
subsection (1) is set out in the Fifth and Sixth Schedules, the person
referred to under subsection (1) is liable, on conviction, to a fine
not exceeding one million penalty units or imprisonment for a term
not exceeding ten years, or to both. 39. (1) Despite any other written law, a person commits
an offence if that person knowingly—
(a) employs, hires, uses, persuades, induces, entices or coerces
a child to contravene this Act; or
Maintaining
controlled
substances
involved
premises
Sale of
controlled
substance to
children
Employing,
hiring, using,
persuading,
inducing,
enticing or
coercing
children to
distribute
drugs

ed
premises
Sale of
controlled
substance to
children
Employing,
hiring, using,
persuading,
inducing,
enticing or
coercing
children to
distribute
drugs

Controlled Substances [No. 2 of 2023 29
(b) employs, hires, uses, persuades, induces, entices or coerces
a child to assist in avoiding detection or apprehension
for any offence under this Act. (2) A person convicted of an offence under subsection (1) is
liable, on conviction, to a fine not exceeding one million penalty
units or to imprisonment for a term not exceeding ten years, or to
both. 40. (1) A person shall not possess a controlled substance
without authorisation under this Act or any other written law. (2) A person who contravenes subsection (1) commits an
offence and is liable, on conviction, to imprisonment for a term not
exceeding fifteen years. (3) This section shall not apply to an appropriate authority
procuring a controlled substance in accordance with the
requirements of any written law. 41. (1) A person who intends to import, export, manufacture
or use prepared opium shall apply for authorisation from the
Authority.

f any written law. 41. (1) A person who intends to import, export, manufacture
or use prepared opium shall apply for authorisation from the
Authority.

(2) A person commits an offence if that person—
(a) imports into, or exports from the Republic any prepared
opium;
(b) manufactures or otherwise deals in prepared opium;
(c) has in that person’s possession any prepared opium;
(d) being the occupier of any premises, permits the premises
to be used for the purpose of the preparation of prepared
opium for smoking, or the sale or smoking, of prepared
opium;
(e) is concerned in the management of any premises used for
purposes of paragraph (d);
(f)has in that person’s possession any pipes or other utensils
for use in connection with the smoking of prepared
opium or any utensils used in connection with the
prepared opium for smoking; or
(g) smokes, or otherwise uses, prepared opium. (2) A person who commits an offence under subsection (1) is
liable, on conviction, to a fine not exceeding one million penalty
units or to imprisonment for a term not exceeding ten years, or to
both. Prohibition
of
possession
of controlled
substance
Offence of
import,
export,
manufacture,
possession
and use of
prepared
opium

ten years, or to
both. Prohibition
of
possession
of controlled
substance
Offence of
import,
export,
manufacture,
possession
and use of
prepared
opium

30 No. 2 of 2023] Controlled Substances
42. A person who commits an offence under this Act for which
a specific penalty is not provided for is liable, on conviction, to a
fine not exceeding three hundred thousand penalty units or to
imprisonment for a term not exceeding three years, or to both. 43. Where an offence under this Act is committed by a body
corporate or unincorporate body, with the knowledge, consent or
connivance of the director, manager shareholder or partner, that
director, manager, shareholder or partner of the body corporate or
unincorporate body commits an offence and is liable, on conviction,
to the penalty specified for that offence. PART IX
GENERAL PROVISIONS
44. The Authority may waive certain requirements under this
Act for the purposes of an importation or exportation of a controlled
substance where a national or global disaster or health emergency
is declared. 45. (1) A person who is aggrieved by a decision made
under this Act may appeal to the Minister within thirty days of the
date of the decision. (2) The Minister shall hear and determine an appeal referred
to under subsection (1) within ninety days from the date of appeal.

date of the decision. (2) The Minister shall hear and determine an appeal referred
to under subsection (1) within ninety days from the date of appeal.

(3) A person aggrieved with the decision of the Minister
under subsection (1), may appeal to the High Court. 46. The Authority shall, in collaboration with the Zambia
Environmental Management Agency and any other appropriate
authority, dispose of expired, obsolete or unwanted controlled
substances. 47. (1) A person in lawful possession of a controlled substance
shall, before ceasing to practise in a profession or being in
employment —
(a) where that person is being succeeded by another person
authorised —
(i) physically check with, and hand over to the
successor all controlled substances;
(ii) submit to the licensee a signed statement, including
the signature of the successor, certifying that
the controlled substances have been physically
checked and handed over in accordance with
subparagraph (i);
General
penalty
Offences by
principal
officer,
shareholder
or partner of
body
corporate or
unincorporate
body
Waiver by
Authority
Appeals
Disposal of
controlled
substance
Requirements
in respect of
cessation of
practise

of
body
corporate or
unincorporate
body
Waiver by
Authority
Appeals
Disposal of
controlled
substance
Requirements
in respect of
cessation of
practise

Controlled Substances [No. 2 of 2023 31
(iii) after handing over the controlled substance, rule
off each page of the register on which an entry
is made, and both the person and the successor
shall, when satisfied that it is a true record of
the controlled substances on hand, sign each
page; and
(iv) if either person is not satisfied that an entry,
under subparagraph (iii), is a true record, that
person shall refuse to sign the page and shall
immediately inform the licensed entity of the
reason for the refusal; or
(b) where that person is not succeeded by another authorised
person—
(i) inform the Authority of the arrangements made
for the disposal of the controlled substances;
and
(ii) immediately after disposing of the controlled
substances, that person shall notify the Authority
of the disposal of the controlled substances and
shall, at the same time, forward the register and
the supporting prescriptions and written orders
to the Authority who shall retain them for a
period of five years from the latest date of entry.

r and
the supporting prescriptions and written orders
to the Authority who shall retain them for a
period of five years from the latest date of entry.

(2) Where the arrangements under subsection (1)(b), are not
made or are not to the satisfaction of the Authority, the controlled
substances shall be disposed of in the manner that the Authority
may determine, in consultation with the Zambia Environmental
Management Agency. 48. Subject to the Forfeiture of Proceeds of Crime Act, 2010,
a person convicted of an offence under this Act shall forfeit to the
Republic all articles in respect of which the offence was committed,
and the court before which that person is convicted may order
those articles to be destroyed or otherwise disposed of as the
court thinks fit at the cost of the convicted person. 49. (1) The Authority may, in the exercise of the Authority’s
functions under this Act, issue guidelines as are necessary for the
better carrying out of the provisions of this Act. (2) The Authority shall publish the guidelines issued under this
Act in the Gazette and any other electronic media that the Authority
may determine. Forfeiture
Act No. 19 of
2010
Guidelines

delines issued under this
Act in the Gazette and any other electronic media that the Authority
may determine. Forfeiture
Act No. 19 of
2010
Guidelines

32 No. 2 of 2023] Controlled Substances
(3) The guidelines shall take effect on the date of publication
and shall bind all persons licensed or authorised under this Act. 50. (1) The Minister may, by statutory instrument, on the
recommendation of the Authority and in consultation with the Drug
Enforcement Commission and any other appropriate authority,
amend the Schedules where it is found that a controlled substance—
(a) has a potential for abuse as categorised in section 27; or
(b) fails to meet the requirements for inclusion in any of the
Schedules. (2) The Minister shall, in amending a Schedule under subsection
(1), take into consideration the—
(a) actual or relative potential for abuse;
(b) scientific evidence of its pharmacological effect, if known;
(c) state of current scientific knowledge regarding a controlled
substance;
(d) history and current pattern of abuse;
(e) scope, duration and significance of abuse;
(f)potential risk to public health;
(g) psychic or physiological dependence liability; or
(h) possibility of the substance being a precursor chemical
of a substance already controlled as specified in this
Act.

gical dependence liability; or
(h) possibility of the substance being a precursor chemical
of a substance already controlled as specified in this
Act.

(3) The Authority shall, in making the recommendation under
subsection (1), consider the decision of the Commission on Narcotic
Drugs on categorisation of a controlled substance. 51. (1) The Minister may, on the recommendation of the
Authority, by statutory instrument, make Regulations for the better
carrying out of the provisions of this Act and for anything required
to be prescribed as specified in this Act. (2) Despite the generality of subsection (1), Regulations made
under subsection (1) may—
(a) provide for measures to prevent diversion of controlled
substances;
(b) provide for the provision of emergency medical services,
a public health emergency or a mass casualty event
using controlled substances, consistent with this Act;
(c) prescribe fees or charges payable in respect of any matter
arising and provided for, or authorised by this Act;
Power of
Minister to
amend
Schedules
Regulations

fees or charges payable in respect of any matter
arising and provided for, or authorised by this Act;
Power of
Minister to
amend
Schedules
Regulations

Controlled Substances [No. 2 of 2023 33
(d) prescribe the forms for applications, licences, approvals,
registers, notices, orders and any other documents
required for the purposes of this Act;
(e) provide for the supply and monitoring of special stocks
and stocks; and
(f) prescribe the information to be given in returns and other
documents submitted or made for the purposes of this
Act.
52. (1) The Dangerous Drugs Act, 1967 is repealed.
(2) Despite subsection (1)—
(a) a licence issued under the repealed Act shall be considered
as having been issued under this Act; and
(b) an application for a licence under the repealed Act shall
be considered and issued in accordance with this Act.
Repeal of
Act No. 42
of 1967 and
savings and
transitional
provisions
Cap. 95

repealed Act shall
be considered and issued in accordance with this Act.
Repeal of
Act No. 42
of 1967 and
savings and
transitional
provisions
Cap. 95

34 No.

34 No.

2 of 2023] Controlled Substances
FIRST SCHEDULE
(Sections 2, 21, 26 and 27)
Part A: Narcotic Drugs
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
Acetorphine 3-O-acetyltetrahydro-7á-(1-hydroxy-1-
methylbutyl)-6,14-endoethenooripavine (derivative
of thebaine)
Acetyl-Alpha-Methylfentanyl N-[1-(á-methylphenethyl)-4- piperidyl]acetanilide
Acetylfentanyl N-[1-(2-phenylethyl)-4-piperidyl]-N-
phenylacetamide
Acetylmethadol 3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Acryloylfentanyl (Acrylfentanyl) N-phenyl-N-[1(2-phenylethyl) piperidin-4-yl]prop-2-
enamide
Alfentanil N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-
yl)ethyl]-4(methoxymethyl)-4-piperidinyl]-N-
phenylpropanamide
AH-7921 3,4-dichloro-N-[(1-
dimethylamino)cyclohexylmethyl]benzamide
Allylprodine 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine
Alphacetylmethadol α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Alphameprodine α-3-ethyl-1-methyl-4-phenyl-4-
propionoxypiperidine
Alphamethadol α-6-dimethylamino-4,4-diphenyl-3-heptanol
Alpha-Methylfentanyl N-[1-(á-methylphenethyl)-4-piperidyl]
propionanilide
Alpha-Methylthiofentanyl N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]
propionanilide
Alphaprodine α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine
Anileridine 1-p-aminophenethyl-4-phenylpiperidine-4-
carboxylic acid ethyl ester
Benzethidine 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-
carboxylic acid ethyl ester
Benzylmorphine 3-benzylmorphine
Betacetylmethadol ß-3-acetoxy-6-dimethylamino-4,4-diphenylheptane
Beta-Hydroxyfentanyl N-[1-(â-hydroxyphenethyl)-4-piperidyl]
propionanilide
Beta-Hydroxy-3- N-[1-(â-hydroxyphenethyl)-3-methyl-4-piperidyl]
Methylfentanyl propionanilide
Betameprodine ß-3-ethyl-1-methyl-4-phenyl-4-
propionoxypiperidine
Betamethadol ß-6-dimethylamino-4,4-diphenyl-3-heptanol
Betaprodine ß-1,3-dimethyl-4-phenyl-4-propionoxypiperidine
Bezitramide 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-
propionyl-1benzimidazolinyl)piperidine
â-3

odine ß-1,3-dimethyl-4-phenyl-4-propionoxypiperidine
Bezitramide 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-
propionyl-1benzimidazolinyl)piperidine
â-3

Controlled Substances [No.

Controlled Substances [No.

2 of 2023 35
Butyrfentanyl N-phenyl-N-[1-(2-phenylethyl)-4-
piperidinyl] butanamide
Cannabis 1
Cannabis Resin, Extracts and
Tinctures _
Carfentanil Methyl 1-(2-phenylethyl)-4-[phenyl (propanoyl)
amino] piperidine-4-carboxylate
Clonitazene 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-
nitrobenzimidazole
Coca Leaf 2 _
Cocaine methyl ester of benzoylecgonine (an alkaloid found in
coca leaves or prepared by synthesis from ecgonine)
Codoxime dihydrocodeinone-6-carboxymethyloxime (derivate of
morphine)
Desomorphine Dihydrodesoxymorphine (derivative of morphine)
Dextromoramide (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-
pyrrolidinyl)butyl]morpholine (dextro-rotatory isomer
of moramide)
Diampromide N-[2-(methylphenethylamino)-propyl] propionanilide
Diethylthiambutene 3-diethylamino-1,1-di-(2’-thienyl)-1-butene
Difenoxin 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic
acid
Dihydroetorphine 7,8-dihydro-7á-[1-(R)-hydroxy-1-methylbutyl]-6,14-
endoethanotetrahydrooripavine (derivative of
etorphine)
Dihydromorphine (derivative of morphine)
Dimenoxadol 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate
Dimepheptanol 6-dimethylamino-4,4-diphenyl-3-heptanol
Dimethylthiambutene 3-dimethylamino-1,1-di-(2’-thienyl)-1-butene
Dioxaphetyl Butyrate ethyl-4-morpholino-2,2-diphenylbutyrate
Diphenoxylate 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-
4-carboxylic acid ethyl ester
Dipipanone 4,4-diphenyl-6-piperidine-3-heptanone
Drotebanol 3,4-dimethoxy-17-methylmorphinan-6â,14-diol
Ecgonine (1R,2R,3S,5S)-3-hydroxy-8-methyl-8-
azabicyclo [3.2.1]octane-2-carboxylic acid
Ethylmethylthiambutene 3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene
Etonitazene 1-diethylaminoethyl-2-p-ethoxybenzyl-5-
nitrobenzimidazole
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
1 the flowering or fruiting tops of the cannabis plant (resin not extracted) the separated resin,
crude or purified, obtained from the cannabis plant
2 the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and
any other ecgonine alkaloids have been removed

plant
2 the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and
any other ecgonine alkaloids have been removed

36 No.

36 No.

2 of 2023] Controlled Substances
Etorphine tetrahydro-7á-(1-hydroxy-1-methylbutyl)-6,14-
endo-ethenooripavine (derivative of the baine)
Etoxeridine 1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-
4-carboxylic acid ethyl ester
Fentanyl 1-phenethyl-4-N-propionylanilinopiperidine
4-Fluoroisobutyrfentanyl N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-
(4-FIBF, pFIBF) yl)isobutyramide
Furanylfentanyl N-phenyl-N-[1-(2-phenylethyl)piperidin-4-
yl]furan-2-carboxamide
Furethidine 1-(2-tetrahydrofurfuryloxyethyl)-4-
phenylpiperidine-4-carboxylic acid ethyl ester
Heroin diacetylmorphine (derivative of morphine)
Hydrocodone dihydrocodeinone (derivative of morphine)
Hydromorphinol 14-hydroxydihydromorphine (derivative of
morphine)
Hydromorphone dihydromorphinone (derivative of morphine)
Hydroxypethidine 4-m-hydroxyphenyl-1-methylpiperidine-4-
carboxylic acid ethyl ester
Isomethadone 6-dimethylamino-5-methyl-4,4-diphenyl-3-
hexanone
Ketobemidone 4-m-hydroxyphenyl-1-methyl-4-
propionylpiperidine
Levomethorphan (-)-3-methoxy-N-methylmorphinan
Levomoramide (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-
pyrrolidinyl)butyl]morpholine
Levophenacylmorphan (-)-3-hydroxy-N-phenacylmorphinan
Levorphanol2 (-)-3-hydroxy-N-methylmorphinan
Metazocine 2-hydroxy-2,5,9-trimethyl-6,7-benzomorphan
Methadone 6-dimethylamino-4,4-diphenyl-3-heptanone
Methadone Intermediate 4-cyano-2-dimethylamino-4,4-diphenylbutane
Methyldesorphine 6-methyl-6-deoxymorphine (derivative of
morphine)
Methyldihydromorphine 6-methyldihydromorphine (derivative of morphine)
3-Methylfentanyl N-(3-methyl-1-phenethyl-4-piperidyl)
propionanilide
3-Methylthiofentanyl N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]
propionanilide
Metopon 5-methyldihydromorphinone (derivative of
morphine)
Moramide Intermediate 2-methyl-3-morpholino-1,1-diphenylpropane
carboxylic acid
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

ethyl-3-morpholino-1,1-diphenylpropane
carboxylic acid
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

Controlled Substances [No.

Controlled Substances [No.

2 of 2023 37
Morpheridine 1-(2-morpholinoethyl)-4-phenylpiperidine-4-
carboxylic acid ethyl ester
Morphine the principal alkaloid of opium and of opium
poppy
Morphine Methobromide3 (5α, 6α)-3,6-Dihydroxy-17,17-dimethy l-7, 8didehydro-
4,5-epoxymorphinan-17-ium bromide
Morphine-N-Oxide (derivate of morphine)
MPPP 1-methyl-4-phenyl-4-piperidinol propionate (ester)
MT-45 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
Myrophine Myristylbenzylmorphine (derivate of morphine)
Nicomorphine 3,6-dinicotinylmorphine (derivate of morphine)
Noracymethadol ()-α-3-acetoxy-6-methylamino-4,4-diphenylheptane
Norlevorphanol (-)-3-hydroxymorphinan
Normethadone 6-dimethylamino-4,4-diphenyl-3-hexanone
Normorphine demethylmorphine (derivate of morphine)
Norpipanone 4,4-diphenyl-6-piperidino-3-hexanone
Ocfentanil N-(2-fluorophenyl)-2-methoxy-N-[1-(2-
phenylethyl)piperidin-4yl]acetamide
Opium the coagulated juice of the opium poppy (plant species
Papaver somniferum L.)
Oripavine 3-O-demethylthebaine
Oxycodone 14-hydroxydihydrocodeinone (derivate of morphine)
Oxymorphone 14-hydroxydihydromorphinone (derivate of morphine)
Para-Fluorofentanyl 4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide
PEPAP 1-phenethyl-4-phenyl-4-piperidinol acetate (ester)
Pethidine 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl
ester
Pethidine Intermediate A 4-cyano-1-methyl-4-phenylpiperidine
Pethidine Intermediate B 4-phenylpiperidine-4-carboxylic acid ethyl ester
Pethidine Intermediate C 1-methyl-4-phenylpiperidine-4-carboxylic acid
Phenadoxone 6-morpholino-4,4-diphenyl-3-heptanone
Phenampromide N-(1-methyl-2-piperidinoethyl)propionanilide
Phenazocine 2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-
benzomorphan
Phenomorphan 3-hydroxy-N-phenethylmorphinan
Phenoperidine 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-
carboxylic acid ethyl ester
Piminodine 4-phenyl-1-(3-phenylaminopropyl)piperidine-4-
carboxylic acid ethyl ester
Piritramide 1-(3-cyano-3,3-diphenylpropyl)-4-(1-
piperidino)piperidine-4carboxylic acid amide
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

yl)-4-(1-
piperidino)piperidine-4carboxylic acid amide
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

38 No.

38 No.

2 of 2023] Controlled Substances
Proheptazine 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane
Properidine 1-methyl-4-phenylpiperidine-4-carboxylic acid
isopropyl ester
Racemethorphan ()-3-methoxy-N-methylmorphinan
Racemoramide ()-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-
pyrrolidinyl)butyl]morpholine
Racemorphan ()-3-hydroxy-N-methylmorphinan
Remifentanil 1-(2-methoxycarbonylethyl)-4-
(phenylpropionylamino)-piperidine-4carboxylic acid
methyl ester
Sufentanil N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-
piperidyl]propionanilide
Tetrahydrofuranylfentanyl (THF-F) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-
yl]tetrahydrofuran-2carboxamide
Thebacon Acetyldihydrocodeinone (acetylated enol form of
hydrocodone)
Thebaine (an alkaloid of opium; also found in Papaver
bracteatum)
Thiofentanyl N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide
Tilidine ()-ethyl-trans-2-(dimethylamino)-1-phenyl-3-
cyclohexene-1carboxylate
Trimeperidine 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine
U-47700 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-
methyl-benzamide
Part B: Psychotropic Substances
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
Brolamfetamine (±)-4-bromo-2,5-dimethoxy-á-methylphenethylamine
Cathinone (–)-(S)-2-aminopropiophenone
DET 3-[2-(diethylamino)ethyl]indole
DMA (±)-2,5-dimethoxy-á-methylphenethylamine
DMHP 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-
trimethyl-6H dibenzo[b,d]pyran-1-ol
DM T 3-[2-(dimethylamino)ethyl]indole
DOET (±)-4-ethyl-2,5-dimethoxy-á-methylphenethylamine
Eticyclidine N-ethyl-1-phenylcyclohexylamine
Etryptamine 3-(2-aminobutyl)indole
(+)-Lysergide 9,10-didehydro-N,N-diethyl-6-methylergoline-8ß-
carboxamide
N-hydroxy MDA (±)-N[α-methyl-3,4-
(methylenedioxy)phenethyl]hydroxylamine
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

[α-methyl-3,4-
(methylenedioxy)phenethyl]hydroxylamine
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

Controlled Substances [No.

Controlled Substances [No.

2 of 2023 39
MDE, N-ethyl (±)-N-ethyl-α-methyl-3,4-
MDA (methylenedioxy)phenethylamine
MDMA (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine
Mescaline 3,4,5-trimethoxyphenethylamine
Methcathinone 2-(methylamino)-1-phenylpropan-1-one
4-methylaminorex (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline
MMDA 5-methoxy-á-methyl-3,4-(methylenedioxy)
phenethylamine
4-MTA α-methyl-4-methylthiophenethylamine
25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine
25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine
25I-NBOMe 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine
Psilocybine 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen
phosphate
Rolicyclidine 1-(1-phenylcyclohexyl)pyrrolidine
2,5-dimethoxy-á,4-dimethylphenethylamine
Tenamfetamine α-methyl-3,4-(methylenedioxy)phenethylamine
Tenocyclidine 1-[1-(2-thienyl)cyclohexyl]piperidine
Tetrahydrocannabinol tetrahydrocannabinol, the following isomers and their
stereochemical variants:
delta-6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
dibenzo[b,d]pyran-1-ol
delta-6a(7)-THC (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-
pentyl-6H dibenzo[b,d]pyran-1-ol
delta-7-THC (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-
3-pentyl-6H dibenzo[b,d]pyran-1-ol
delta-8-THC (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-
pentyl-6H dibenzo[b,d]pyran-1-ol
delta-10-THC 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
dibenzo[b,d]pyran-1-ol
delta-9(11)-THC (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-
methylene3 pentyl-6H-dibenzo[b,d] pyran-1-ol
TMA (±)-3,4,5-trimethoxy-á-methylphenethylamine
Part B: Psychotropic Substances
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

á-methylphenethylamine
Part B: Psychotropic Substances
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name

40 No.

40 No.

2 of 2023] Controlled Substances
SECOND SCHEDULE
(Sections 2,21,26 and 27)
Part A: Narcotic Drugs
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
Acetyldihydrocodeine (derivative of codeine)
Codeine 3-methylmorphine (derivate of morphine, alkaloid
contained in opium and poppy straw)
Dextropropoxyphene α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-
2butanol propionate (Dextro-rotary isomer of
propoxyphene)
Dihydrocodeine (derivative of morphine)
Ethylmorphine 3-ethylmorphine (derivative of morphine)
Nicocodine 6-nicotinylcodeine (derivative of morphine)
Nicodicodine 6-nicotinyldihydrocodeine (derivative of morphine)
Norcodeine N-demethylcodeine (derivative of morphine)
Pholcodine morpholinylethylmorphine (derivative of morphine)
Propiram N-(1-methyl-2-piperidinoethyl)-N-
2pyridylpropionamide
Part B: Psychotropic Substances
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
AM-2201 [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-
1yl)methanone
Amfetamine (±)-α-methylphenethylamine
Amineptine 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5
yl)amino]heptanoic acid
5F-APINACA
N-Benzylpiperazine 1-benzylpiperazine
4-bromo-2,5-dimethoxyphenethylamine
Dexamfetamine (+)-á-methylphenethylamine
Dronabinola (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-
3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Ethylone
Ethylphenidate
Fenetylline 7-[2-[(á- methylphenethyl)amino]ethyl]theophylline
JWH-018 Naphthalene-1-yl(1-pentyl-1H-indol-3-yl) methanone
Levamfetamine (–)-(R)-α-methylphenethylamine(amphetamine
(-)isomer
MDMB-CHMICA

theophylline
JWH-018 Naphthalene-1-yl(1-pentyl-1H-indol-3-yl) methanone
Levamfetamine (–)-(R)-α-methylphenethylamine(amphetamine
(-)isomer
MDMB-CHMICA

Controlled Substances [No. 2 of 2023 41
International non-proprietary
name or other non-proprietary
name or trivial names Chemical name
MDPV (R/S)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-
1-yl)pentan-1-one
Mecloqualone 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone
Mephedrone (RS)-2-methylamino-1-(4-methylphenyl)propan-
1-one
Metamfetamine (+)-(S)-N,á-dimethylphenethylamine
Metamfetamine Racemate (±)-N,á-dimethylphenethylamine
Methaqualone 2-methyl-3-o-tolyl-4(3H)-quinazolinone
Methiopropamine
Methoxetamine 2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone
4-Methylethcathinone (RS)-2-methylamino-1-(4-methylphenyl)propan-1-one
Methylone (RS)- 2-methylamino-1-
(3,4-methylenedioxyphenyl)propan-1-one
Methylphenidate methyl á-phenyl-2-piperidine acetate
Pentedrone
Phencyclidine 1-(1-phenylcyclohexyl)piperidine
Phenmetrazine 3-methyl-2-phenylmorpholine
Secobarbital 5-allyl-5-(1-methylbutyl)barbituric acid
XLR-11
ZIPEPROL α-(α-methoxybenzyl)-4-(ß-methoxyphenethyl)-1-
piperazineethanol

phenylmorpholine
Secobarbital 5-allyl-5-(1-methylbutyl)barbituric acid
XLR-11
ZIPEPROL α-(α-methoxybenzyl)-4-(ß-methoxyphenethyl)-1-
piperazineethanol

42 No. 2 of 2023] Controlled Substances
THIRD SHEDULE
(Sections 2,21 and 27)
Part A: Preparations Containing Narcotic Drugs
Preparations Containing Narcotic Drugs Contents
Acetyldihydrocodeine, Codeine,
Dihydrocodeine, Ethylmorphine,
Nicocodine, Nicodicodine, Norcodeine,
Pholcodine
Propiram
Dextropropoxyphene
Cocaine
Opium or Morphine
Difenoxin
Diphenoxylate
Pulvis ipecacuanhae et opii compositus
Preparations conforming to any of the formulas listed in this Schedule and mixtures of such
preparations with any material which contains no drug. Preparations containing ephedrine, pseudoephedrine and norephedrine, as follows:
when compounded with one or more other
ingredients and containing not more than 100
milligrams of the drug per dosage unit and with
a concentration of not more than 2.5 per cent in
undivided preparations. containing not more than 100 milligrams of
PROPIRAM per dosage unit and compounded
with at least the same amount of
methylcellulose.

ded preparations. containing not more than 100 milligrams of
PROPIRAM per dosage unit and compounded
with at least the same amount of
methylcellulose.

for oral use containing not more than 135
milligrams of DEXTROPROPOXYPHENE
base per dosage unit or with a concentration of
not more than 2.5 per cent in undivided
preparations, provided that such preparations
do not contain any substance controlled under
the 1971 Convention on Psychotropic
Substances. containing not more than 0.1 per cent of cocaine
calculated as COCAINE base;
containing not more than 0.2 per cent of
MORPHINE calculated as anhydrous
MORPHINE base and compounded with one
or more other ingredients and in such a way
that the drug cannot be recovered by readily
applicable means or in a yield which would
constitute a risk to public health. containing, per dosage unit, not more than 0.5
milligrams of DIFENOXIN and a quantity of
atropine sulfate equivalent to at least 5 per
cent of the dose of DIFENOXIN. containing, per dosage unit, not more than 2.5
milligrams of DIPHENOXYLATE calculated
as base and a quantity of atropine sulfate
equivalent to at least 1 per cent of the dose of
DIPHENOXYLATE. 10 per cent OPIUM in powder; 10 per cent
ipecacuanha root, in powder, well mixed with
80 per cent of any other powdered ingredient
containing no drug.

10 per cent OPIUM in powder; 10 per cent
ipecacuanha root, in powder, well mixed with
80 per cent of any other powdered ingredient
containing no drug.

Controlled Substances [No. 2 of 2023 43
Part B: Psychotropic Substances
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name
Amobarbital 5-ethyl-5-isopentylbarbituric acid
Buprenorphine 2l-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-
trimethylpropyl]-6,14 endo-ethano-6,7,8,14-
tetrahydrooripavine
Butalbital 5-allyl-5-isobutylbarbituric acid
Cathine (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol
Cyclobarbital 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid
Etizolam
Flualprazolam
Flunitrazepam 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-
2H-1,4 benzodiazepin-2-one
Glutethimide 2-ethyl-2-phenylglutarimide
Pentazocine (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-
dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-
benzazocin-8-ol
Pentobarbital 5-ethyl-5-(1-methylbutyl)barbituric acid

1R*)-1,2,3,4,5,6-hexahydro-6,11-
dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-
benzazocin-8-ol
Pentobarbital 5-ethyl-5-(1-methylbutyl)barbituric acid

44 No.

44 No.

2 of 2023] Controlled Substances
FOURTH SCHEDULE
(Sections 2, 21 and 27)
Part A: Narcotic Drugs
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name
Acetorphine 3-O-acetyltetrahydro-7α-(1-hydroxy-1-
methylbutyl)-6,14-endo-ethenooripavine
(derivative of thebaine)
Acetyl-Alpha-Methylfentanyl N-[1-(α-methylphenethyl)-4-
piperidyl]acetanilide
Acetylfentanyl N-Phenyl-N-[1-(2-phenylethyl)-
4piperidinyl]acetamide
Alpha-Methylfentanyl N-[1-(α-methylphenethyl)-4-
piperidyl]propionanilide
Alpha-Methylthiofentanyl N-[1-[1-methyl-2-(2-thienyl)ethyl]-
4piperidyl]propionanilide
Beta-Hydroxyfentanyl N-[1-(ß-hydroxyphenethyl)-4-
piperidyl]propionanilide
Beta-Hydroxy-3-Methylfentanyl N-[1-(ß-hydroxyphenethyl)-3-methyl-
4piperidyl]propionanilide
Cannabis (Plant)4 _
Cannabis Resin5 _
Carfentanil Methyl 1-(2-phenylethyl)-4-
[phenyl(propanoyl)amino]piperidine-4-
carboxylate
Desomorphine dihydrodesoxymorphine (derivative of
morphine)
Etorphine tetrahydro-7á-(1-hydroxy-1-methylbutyl)-
6,14-endoethenooripavine (derivative of
thebaine)
Heroin Diacetylmorphine (derivative of morphine)
Ketobemidone 4-m-hydroxyphenyl-1-methyl-4-
propionylpiperidine
3-Methylfentanyl N-(3-methyl-1-phenethyl-4-
piperidyl)propionanilide
3-Methylthiofentanyl N-[3-methyl-1-[2-(2-thienyl)ethyl]-
4piperidyl]propionanilide
M p p p 1-methyl-4-phenyl-4-piperidinol
propionate (ester)
Para-Fluorofentanyl 4’-fluoro-N-(1-phenethyl-4-
piperidyl)propionanilide
Pepap 1-phenethyl-4-phenyl-4-piperidinol acetate
(ester)
Thiofentanyl N-[1-[2-(thienyl)ethyl]-4-
piperidyl]propionanilide
4 the flowering or fruiting tops of the cannabis plant (resin not extracted)
5 the separated resin, crude or purified, obtained from the cannabis plant

the flowering or fruiting tops of the cannabis plant (resin not extracted)
5 the separated resin, crude or purified, obtained from the cannabis plant

Controlled Substances [No.

Controlled Substances [No.

2 of 2023 45
Part B: Psychotropic Substances
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name
Allobarbital 5,5-diallylbarbituric acid
Alprazolam 8-chloro-1-methyl-6-phenyl-4H-s-
triazolo[4,3 α][1,4]benzodiazepine
Amfepramone 2-(diethylamino)propiophenone
Aminorex 2-amino-5-phenyl-2-oxazoline
Barbital 5,5-diethylbarbituric acid
Benzfetamine N-benzyl-N,a-dimethylphenethylamine
Bromazepam 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-
benzodiazepin- 2-one
Brotizolam 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-
thieno[3,2-f]-s triazolo[4,3-
a][1,4]diazepine
Butobarbital 5-butyl-5-ethylbarbituricacid
Camazepam 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-
5-phenyl-2H-1,4 benzodiazepin-2-one
dimethylcarbamate (ester)
Chlordiazepoxide 7-chloro-2-(methylamino)-5-phenyl-3H-1,4
benzodiazepine-4-oxide
Clobazam 7-chloro-1-methyl-5-phenyl-1H-1,5-
benzodiazepine-2,4(3H,5H)-dione
Clonazepam 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-
1,4 benzodiazepin-2-one
Clorazepate 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-
1,4 benzodiazepine-3-carboxylic acid
Clotiazepam 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-
methyl-2H thieno[2,3-e]-1,4-
diazepin-2-one
Cloxazolam 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-
tetrahydro oxazolo-[3,2-
d][1,4]benzodiazepin-6(5H)-one
Delorazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-
2H-1,4 benzodiazepin-2-one
Diazepam 7-chloro-1,3-dihydro-1-methyl-5-phenyl-
2H-1,4 benzodiazepin-2-one
Estazolam 8-chloro-6-phenyl-4H-s-triazolo[4,3-
α][1,4]benzodiazepine
Ethchlorvynol 1-chloro-3-ethyl-1-penten-4-yn-3-ol
Ethinamate 1-ethynylcyclohexanolcarbamate
Ethyl Loflazepate ethyl 7-chloro-5-(o-fluorophenyl)-2,3-
dihydro-2-oxo-1H 1,4- benzodiazepine-3-
carboxylate
Etilamfetamine N-ethyl-α-methylphenethylamine

l Loflazepate ethyl 7-chloro-5-(o-fluorophenyl)-2,3-
dihydro-2-oxo-1H 1,4- benzodiazepine-3-
carboxylate
Etilamfetamine N-ethyl-α-methylphenethylamine

46 No.

46 No.

2 of 2023] Controlled Substances
5
10
15
Fencamfamin N-ethyl-3-phenyl-2-norbornanamine
Fenproporex (±)-3-[(α-
methylphenylethyl)amino]propionitrile
Fludiazepam 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-
methyl-2H-1,4 benzodiazepin-2-one
Flurazepam 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-
fluorophenyl)-1,3 dihydro-2H-
1,4-benzodiazepin-2-one
Halazepam 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-
trifluoroethyl)-2H- 1,4- benzodiazepin-2-
one
Haloxazolam 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-
tetrahydrooxazolo[3,2-d]
[1,4]benzodiazepin-6(5H)-one
Ketazolam 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-
phenyl-4H- [1,3]oxazino[3,2-
d][1,4]benzodiazepin-4,7(6H)-dione
Lefetamine (–)-N,N-dimethyl-1,2-diphenylethylamine
Loprazolam 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-
methyl-1-piperazinyl) methylene]-8-
nitro-1H-imidazo[1,2-
α][1,4]benzodiazepin-1-one
Lorazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-
hydroxy-2H-1,4 benzodiazepin-2-one
Lormetazepam 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-
hydroxy-1 methyl-2H-1,4-
benzodiazepin-2-one
Mazindol 5-(p-chlorophenyl)-2,5-dihydro-3H-
imidazo[2,1-a]isoindol-5-ol
Medazepam 7-chloro-2,3-dihydro-1-methyl-5-phenyl-
1H-1,4 benzodiazepine
Mefenorex N-(3-chloropropyl)-α-
methylphenethylamine
Meprobamate 2-methyl-2-propyl-1,3-
propanedioldicarbamate
Mesocarb 3-(á-methylphenethyl)-N-
(phenylcarbamoyl)sydnone imine
Methylphenobarbital 5-ethyl-1-methyl-5-phenylbarbituric acid
Methyprylon 3,3-diethyl-5-methyl-2,4-piperidine-dione
Midazolam 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-
imidazo[1,5 α][1,4]benzodiazepine
Nimetazepam 1,3-dihydro-1-methyl-7-nitro-5-phenyl-
2H-1,4 benzodiazepin-2-one
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name

-1-methyl-7-nitro-5-phenyl-
2H-1,4 benzodiazepin-2-one
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name

Nitrazepam 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-
benzodiazepin-2-one
Nordazepam 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-
benzodiazepin-2-one
Oxazepam 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-
2H-1,4 benzodiazepin-2-one
Oxazolam 10-chloro-2,3,7,11b-tetrahydro-2-methyl-
11b phenyloxazolo[3,2-
d][1,4]benzodiazepin- 6(5H)-one
Pemoline 2-amino-5-phenyl-2-oxazolin-4-one
Phenazepam 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-
2H-1,4 benzodiazepin-2-one
Phendimetrazine (+)-(2S,3S)-3,4-dimethyl-2-
phenylmorpholine
Phenobarbital 5-ethyl-5-phenylbarbituric acid
Phentermine α,α-dimethylphenethylamine
Pinazepam 7-chloro-1,3-dihydro-5-phenyl-1-(2-
propynyl)-2H-1,4 benzodiazepin-2- one
Pipradrol 1,1-diphenyl-1-(2-piperidyl)methanol
Prazepam 7-chloro-1-(cyclopropylmethyl)-1,3-
dihydro-5-phenyl-2H- 1,4-benzodiazepin-
2-one
Pyrovalerone 4’-methyl-2-(1-pyrrolidinyl)valerophenone
Secbutabarbital 5-sec-butyl-5-ethylbarbituric acid
Temazepam 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-
5-phenyl-2H-1,4 benzodiazepin-2-one
Tetrazepam 7-chloro-5-(1-cyclohexen-1-yl)-1,3-
dihydro-1-methyl-2H- 1,4-
benzodiazepin-2-one
Triazolam 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-
s-triazolo[4,3 a][1,4] benzodiazepine
Vinylbital 5-(1-methylbutyl)-5-vinylbarbituric acid
Zolpidem N,N,6-trimethyl-2-p-tolylimidazo[1,2-
a]pyridine-3 acetamide
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name
Controlled Substances [No.

1,2-
a]pyridine-3 acetamide
International non-proprietary name
or other non-proprietary name or
trivial names Chemical name
Controlled Substances [No.

2 of 2023 47

2 of 2023 47

FIFTH SCHEDULE
(Sections 2, 21, 23, 26, 27 and 38)
Precursor chemicals
Name Chemical names /descriptions
N-Acetylanthranilic acid (benzoic acid, 2-(acetylamino)-)
4-Anilino-N- (N-phenyl-1-(2-
phenethylpiperidine phenylethyl)piperidin-4-amine)
Name Chemical names /descriptions
(ANPP) 2
Ephedrine ([R-(R*,S*)]-α-[1-
(methylamino)ethyl]-
benzenemethanol)
Ergometrine (ergoline-8-carboxamide,9,10-
didehydro-N-(2-
hydroxy- 1-methylethyl)-6-methyl-
[8ß(S)])
Ergotamine (ergotaman-3',6',18'-trione, 12'-
hydroxy-2'-
methyl-5'- (phenylmethyl)-,(5α))
Isosafrole (1,3-benzodioxole,5-(1-propenyl)-)
((8ß)-9,10-didehydro-6-
Lysergic acid methylergoline-8-
carboxylic acid)
3,4-Methylenedioxyphenyl-2- (2-propanone,1-
propanone [3,4(methylenedioxy)phenyl]-)
(R*,S*)-α-(1-
Norephedrine aminoethyl)benzenemethanol
N-Phenethyl-4-piperidone (1-(2-phenylethyl)-piperidin-4-one)
(NPP)2
Phenylacetic acid (benzeneacetic acid)
1-Phenyl-2-propanone (1-phenyl-2-propanone)
alpha-Phenylacetoacetonitrile
(APAAN) (3-oxo-2-phenylbutanenitrile)
(1,3-benzodioxole-5-
Piperonal carboxaldehyde)
Pseudoephedrine ([S-(R*,R*)]-α-[1-
benzenemethanol) (methylamino)ethyl]-
Safrole (1,3-benzodioxole,5-(2-propenyl)-)
Piperidine Piperidine
The salts of the substances listed in this part whenever the existence of such salts is
possible
This part may include preparations and substances that pose a potential threat to public health
and includes anabolic steroids.

such salts is
possible
This part may include preparations and substances that pose a potential threat to public health
and includes anabolic steroids.

48 No. 2 of 2023] Controlled Substances

SIXTH SCHEDULE
(Section 2,5,26 and 38)
Name Chemical names
Acetic anhydride (acetic oxide)
Potassium permanganate (permanganic acid (HMnO4), potassium salt)
Ethyl ether (1,1’-oxybis[ethane])
Hydrochloric acid [1] (hydrochloric acid)
Methyl ethyl ketone (2-butanone)
Sulphuric acid (sulfuric acid)
Toluene (benzene, methyl-)
The salts of the substances listed in this part whenever the existence of such salts is possible (the
salts of hydrochloric acid and sulphuric acid are specifically excluded)
Controlled Substances [No. 2 of 2023 49

5 0